An observational study in Vertebral Compression Fracture, Korean Traditional Medicine and Integrative Korean Medicine, sponsored by Jaseng Medical Foundation. Completed at 1 site in South Korea. Open to participants aged 19 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-03-05.
Sponsored by Jaseng Medical Foundation · Observational
The purpose of this study is to reveal the effectiveness and safety of integrative Korean medicine for Vertebral Compression Fracture in-patients by observing inpatients treated with integrative Korean medicine.
This study is a retrospective observational study. The subjects for study are patients diagnosed with Vertebral Compression Fracture and who have been admitted to four Jaseng Hospital of Korean medicine (Gangnam, Bucheon, Daejeon, and Haeundae) for 2016.04.01-2022.06.30.
Medical records of selected patients will be analyzed, and telephone surveys will be conducted for each patient. The survey questions are Numeric ratinc scale (NRS), Oswestry Disability Index(ODI), quality of life, and Patient Global Impression of Change (PGIC), etc.
50 studies on the registry are indexed under Fractures, Compression; 10 are open to participants now.
This study's enrollment of 70 is below the median of 100 across 16 observational studies indexed under Fractures, Compression.
Browse Fractures, Compression studies →Jaseng Medical Foundation is the lead sponsor of 69 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Recruit people who meet the selection criteria and conduct a telephone survey.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
A questionnaire about the current symptoms and satisfaction for received treatment will be conducted over the phone for patients.
Numeric rating scale (NRS)
NRS uses an 11-point scale to evaluate current neck pain and radiating pain where no pain is indicated by '0', and the worst pain imaginable by '10'. NRS was assessed at admission, 2 weeks after admission, discharge, and long term follow up.
Time frame: [Time Frame: Finish survey by November 2023]
Oswestry Disability Index(ODI)
ODI is a 10-item questionnaire developed to evaluate the degree of disability for lower back pain. Each item is divided into 6 levels, and 0 to 5 points are awarded. The higher the score, the greater the degree of disability. The investigators will conduct an validated Korean NDI questionnaire
Time frame: [Time Frame: Finish survey by November 2023]
The five level version of EuroQol-5 Dimension (EQ-5D)
EQ-5D is most widely used as a method of indirectly calculating the quality of life from various aspects. The EQ-5D-5L consists of 5 questions (mobility, self-care, usual activities, pain, anxiety/depression) that ask about the current state of health, and answers each question with 5 likert. (1=I have no problems about, 2=I have slight problems about, 3=I have moderate problems about, 4=I have severe problems about, 5=I am unable to about) In this study, the validated Korean version questionnaire will be used.
Time frame: [Time Frame: Finish survey by November 2023]
Patient Global Impression of Change (PGIC)
PGIC is an indicator that evaluates the improvement of patients in 7 steps, and the subject responds with improvement of functional limitation after treatment with 7 likert. (1=very much improved, 2=much improved, 3=minimally improved, 4=no change, 5=minimally worse, 6=much worse, 7=very much worse).
Time frame: [Time Frame: Finish survey by November 2023]
Spine Operation
Operation status
Time frame: [Time Frame: Finish survey by November 2023]
Treatment after discharge survey
Treatment history after discharge
Time frame: [Time Frame: Finish survey by November 2023]
Satisfaction with integrative Korean medicine survey
Preference for integrative Korean medicine, satisfaction with integrative Korean medicine, How helpful hospitalization has been for returning to work and adjusting to daily life.
Time frame: [Time Frame: Finish survey by November 2023]
Plan to share: No
Ran from Jan 2023 to primary completion in Feb 2024, 13 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Jaseng Medical Foundation